Russia Develops Vaccine Against New Ebola Strain; Cases Rising in Africa
मुख्य बातें
- •Russia claims to have developed a vaccine against the new Ebola strain, 'Bundibugyo'.
- •Ebola cases are increasing in Africa, straining healthcare systems.
- •Symptoms of Ebola include high fever, weakness, vomiting, diarrhea, and bleeding, with a fatality rate of 50% to 90%.
- •Clinical trials and scientific evaluations are necessary before the vaccine can be widely used.
The World Health Organization and other global health agencies have raised concerns over a new strain of the Ebola virus. Russia has now claimed a significant breakthrough in this regard. Russian Health Minister Mikhail Murashko recently announced that scientists in the country have developed an effective vaccine against the new Ebola strain, 'Bundibugyo'. This strain is rapidly spreading in some African nations, putting immense pressure on their healthcare systems. Experts believe this strain may be more contagious and deadly than previously known strains, further increasing the urgency for a vaccine.
Ebola virus primarily spreads through bodily fluids of an infected person. Its key symptoms include high fever, extreme weakness, vomiting, diarrhea, and in severe cases, bleeding. According to the WHO, the fatality rate of Ebola can range from 50% to 90%, making it one of the world's most dangerous diseases. Several African countries have seen a recent surge in Ebola cases, heightening concerns among global health officials. Experts warn that the 'Bundibugyo' strain could spread faster than earlier strains and may lead to severe health complications more quickly.
